Cancer-evolution intelligence
Staying a step ahead of resistance
The same drugs are still given by protocol and hope, with no way to know if they are working. In2Cell reads the genome directly to show whether a treatment is actually reaching the tumour, before it goes near the patient.
How POLEX works
We begin from the patient's own tumour, taken as a small biopsy.
The tumour is grown into living organoids and tested with candidate drugs.
A neural network reads genetic instability before and after treatment, pointing to the best-in-class option. See the platform →
Get in touch
We're raising a pre-seed round, and looking for clinical, research, and funding partners who want to take the guesswork out of cancer treatment.